ACADIA Pharmaceuticals Inc — Cash Flow (NASDAQ:ACAD) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 136.17 M125.66 M114.03 M16.7 M157.72 M109.84 M 109.84 M Cash from investing activities 192.51 M71.1 M73.24 M32 M30.54 M302.56 M 302.56 M Cash from financing activities 81 M18.16 M8.2 M25.13 M6.84 M49.88 M 49.88 M Free cash flow 128.58 M124.54 M114.03 M-23.35 M157.2 M6.31 M 11 M

ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Notícias

Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs (ACAD)

ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth

Jefferies eleva preço-alvo das ações da Acadia Pharmaceuticals

Jefferies raises Acadia Pharmaceuticals stock price target on guidance

Citizens eleva preço-alvo da Acadia Pharmaceuticals com perspectiva de crescimento

Citizens raises Acadia Pharmaceuticals price target on growth outlook

ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ACAD) 2026-02-25

Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates

ACADIA Q4 2025 slides: $1B revenue milestone as both drugs post double-digit growth

Resultados da Acadia à vista: crescimento de Receita esperado apesar da queda nos lucros

Wolfe Research inicia cobertura de ações da Acadia com classificação outperform